Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK9 | P50750 | 18/20 | 1.00 |
| ▸ | CCNT1 | O60563 | 17/20 | 1.00 |
| ▸ | CDK4 | P11802 | 9/20 | 0.78 |
| ▸ | CCND1 | P24385 | 9/20 | 0.78 |
| ▸ | CDK2 | P24941 | 9/20 | 0.78 |
| ▸ | CDK7 | P50613 | 9/20 | 0.78 |
| ▸ | CCNH | P51946 | 8/20 | 0.78 |
| ▸ | CCNE1 | P24864 | 6/20 | 0.78 |
| ▸ | CCNA1 | P78396 | 6/20 | 0.78 |
| ▸ | CDK3 | Q00526 | 6/20 | 0.78 |
| ▸ | CDK1 | P06493 | 5/20 | 0.78 |
| ▸ | CCNA2 | P20248 | 5/20 | 0.78 |
| ▸ | CDK6 | Q00534 | 5/20 | 0.78 |
| ▸ | CDK5 | Q00535 | 4/20 | 0.78 |
| ▸ | CDK5R1 | Q15078 | 4/20 | 0.78 |
| ▸ | CCNC | P24863 | 2/20 | 0.66 |
| ▸ | CDK13 | Q14004 | 2/20 | 0.66 |
| ▸ | CDK12 | Q9NYV4 | 2/20 | 0.66 |
| ▸ | CCNK | O75909 | 1/20 | 0.66 |
| ▸ | CDK14 | O94921 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29558312 | 0.99 | CDK9 (0.98) | CDK9CCNT1CDK4CCND1CDK2 | |
| SCHEMBL24418614 | 0.88 | CDK9 (0.79) | CDK9CCNT1CDK4CCND1CDK2 | |
| SCHEMBL21946122 | 0.88 | CDK9 (1.00) | CDK9CCNT1CDK4CCND1CDK2 | |
| SCHEMBL24418642 | 0.87 | CDK9 (0.77) | CDK9CCNT1CDK4CCND1CDK2 | |
| SCHEMBL24418635 | 0.87 | CDK9 (0.77) | CDK9CCNT1CDK4CCND1CDK2 | |
| SCHEMBL24418837 | 0.85 | CDK9 (0.74) | CDK9CCNT1CDK4CCND1CDK2 | |
| SCHEMBL26874107 | 0.85 | CDK9 (0.82) | CDK9CCNT1CDK4CCND1CDK2 | |
| SCHEMBL26874256 | 0.85 | CDK9 (0.82) | CDK9CCNT1CDK4CCND1CDK2 | |
| SCHEMBL29558118 | 0.83 | CCNT1 (0.71) | CDK9CCNT1CDK4CCND1CDK2 | |
| SCHEMBL21946526 | 0.81 | CDK9 (0.72) | CDK9CCNT1CDK4CCND1CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250188084-A1 | COMPOUNDS AND METHODS FOR MODULATING CDK9 ACTIVITY | Kronos Bio, Inc. (US) | 2025-06-12 | — | — | US | disclosed |
| EP-4240422-A1 | COMPOUNDS AND METHODS FOR MODULATING CDK9 ACTIVITY | Kronos Bio, Inc. (US) | 2023-09-13 | — | — | EP | disclosed |
| WO-2022098843-A1 | COMPOUNDS AND METHODS FOR MODULATING CDK9 ACTIVITY | Kronos Bio, Inc. (US) | 2022-05-12 | — | — | WO | disclosed |
| WO-2022098843-A1 | COMPOUNDS AND METHODS FOR MODULATING CDK9 ACTIVITY | Kronos Bio, Inc. (US) | 2022-05-12 | — | — | WO | disclosed |
| US-20220002305-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CDK9 ACTIVITY | Kronos Bio, Inc. (US) | 2022-01-06 | — | — | US | disclosed |
| US-11155560-B2 | Substituted pyrazolo[1,5-a]pyrimidines for modulating CDK9 activity | Kronos Bio, Inc. (US) | 2021-10-26 | — | — | US | disclosed |
| US-20200131189-A1 | Compounds, Compositions, and Methods for Modulating CDK9 Activity | IGNOTA LABS LIMITED (GB) | 2020-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200131189-A1 | Compounds, Compositions, and Methods for Modulating CDK9 Activity | CDK9, CDK19, CDK7 | CDK9 1/4885CCNT1 55/4885CDK4 11/4885 |
| US-20250188084-A1 | COMPOUNDS AND METHODS FOR MODULATING CDK9 ACTIVITY | CDK9, CDK19, CDKL1 | CDK9 1/4885CCNT1 86/4885CDK4 8/4885 |
| US-20220002305-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CDK9 ACTIVITY | CDK9, CDK19, CDK7 | CDK9 1/4885CCNT1 55/4885CDK4 11/4885 |
| US-11155560-B2 | Substituted pyrazolo[1,5-a]pyrimidines for modulating CDK9 activity | CDK9, CDK19, CDK7 | CDK9 1/4885CCNT1 40/4885CDK4 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.